How influential are Patient and professional group submissions on reimbursement decisions for European Medicines Agency Orphan Drugs?
May 1, 2015, 00:00
10.1016/j.jval.2015.03.1780
https://www.valueinhealthjournal.com/article/S1098-3015(15)01837-9/fulltext
Title :
How influential are Patient and professional group submissions on reimbursement decisions for European Medicines Agency Orphan Drugs?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01837-9&doi=10.1016/j.jval.2015.03.1780
First page :
A306
Section Title :
Systemic Disorders/Conditions
Open access? :
No
Section Order :
1271